Pharma Tariffs Push for U.S. Production
What the New Pharma Tariff Means for CDMOs and Sterile Injectables The U.S. just announced a proposed 100% tariff on imported branded drugs unless com...
Read More
Bigger and Built to Deliver.
In sterile injectable manufacturing, growth isn’t optional, it’s key.
American Injectables Announces Key Leadership Appointments to Drive Future Growth
American Injectables, a leading contract development and manufacturing organization (CDMO) specializ...
American Injectables Earns FDA Approval
BROOKSVILLE, FL (January 9, 2025) — American Injectables, a contract development and manufacturing o...
A Business-Minded Guide to Injectable Solutions and Market Trends
You don’t need a PhD in biochemistry to work in the pharmaceutical industry. However, understanding ...
Pharmaceutical Data Integrity: Protecting Your Branded Formulation
Imagine spending years and hundreds of thousands of dollars on a formulation, only to have it compro...
Special Considerations for Developing Parenteral Formulations
Compared to oral and transdermal medicine, parenteral formulations are potent and fast-acting. With ...
Strengthening the Pharmaceutical Supply Chain: It Starts With Formulation
The effects of supply chain issues are often most noticeable at the consumer level, manifesting as p...
Developing a Regulatory Strategy: Key Studies in the Formulation Stage
The FDA approval process is time-intensive and difficult for good reason. If you emerge on the other...
Formulation Development Process for Injectables: Your Steps to Success [Graphic]
Formulation development can take as long as three U.S. presidential terms. With that kind of time, i...